Pier 88 Investment Partners LLC Guardant Health, Inc. Transaction History
Pier 88 Investment Partners LLC
- $77.7 Million
- Q3 2025
A detailed history of Pier 88 Investment Partners LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 16,650 shares of GH stock, worth $1.57 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
16,650
Previous 12,400
34.27%
Holding current value
$1.57 Million
Previous $645,000
61.24%
% of portfolio
1.34%
Previous 0.76%
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
450Shares Held
125MCall Options Held
2.18MPut Options Held
2.69M-
Vanguard Group Inc Valley Forge, PA11.9MShares$1.12 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$1.06 Billion0.01% of portfolio
-
Baillie Gifford & CO5.13MShares$484 Million0.25% of portfolio
-
Invesco Ltd. Atlanta, GA4.93MShares$465 Million0.05% of portfolio
-
Capital International Investors Los Angeles, CA4.69MShares$443 Million0.05% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $9.65B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...